Sperimentazione Clinica in italia

 

La lista completa delle sperimentazioni cliniche in Italia può essere ottenuta tramite il sito

www.clinicaltrials.gov

Al 26 maggio2010 vi sono 134 clinical trials attivi in cui sono coinvolti gruppi di ricerca italiani. 

 

 

You can find further information on Hide studies that are not seeking new volunteers.  

Rank Status Study
1 Active, not recruiting Hematopoietic Stem Cell Transplantation in Myeloma
Condition: Multiple Myeloma
Intervention: Procedure: Hematopoietic Stem Cell Transplantation
2 Recruiting A Remission Induction Therapy and Risk-oriented Postremission Strategy for Adult Acute Myelogenous Leukemia (AML)
Condition: Acute Myelogenous Leukemia
Intervention: Drug: cytosine arabinoside
3 Recruiting Dose-Reduced Versus Standard Conditioning Prior Allo SCT for MDS/sAML Patients
Conditions: Myelodysplastic Syndrome;   Secondary Acute Myeloid Leukemia
Interventions: Procedure: Standard conditioning prior allo SCT;   Procedure: Dose-reduced conditioning prior allo SCT
4 Recruiting Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant
Condition: Cancer
Intervention: Drug: caspofungin acetate
5 Completed A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous Leukemia
Condition: Acute Myelogenous Leukemia
Intervention: Behavioral: Two-step remission induction and risk-oriented consolidation
6 Recruiting Efficacy and Safety of Donor Lymphocytes Depleted of Alloreactive T-cells (ATIR™) in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor
Conditions: Myeloid Leukemia;   Lymphoblastic Leukemia;   Lymphoma;   Multiple Myeloma;   Myelodysplastic Syndrome;   Myeloproliferative Disorders
Intervention: Biological: Donor lymphocyte preparation depleted of functional alloreactive T-cells
7 Recruiting High Dose Therapy and Peripheral Blood Stem Cell Transplantation in HIV Related Non Hodgkin Lymphoma (NHL) at High Risk
Conditions: HIV-Related Lymphoma;   HIV Infections
Intervention: Other: Rituximab and CHOP regimen + PBSCT
8 Recruiting Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)
Condition: Multiple Myeloma
Intervention: Procedure: Hematopoietic Stem Cell Transplantation
9 Completed Effect of Sitagliptin on Endothelial Progenitor Cells
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: Sitagliptin
10 Recruiting Bone Marrow Progenitor Cell Mobilization in Diabetes
Condition: Diabetes Mellitus
Intervention: Drug: Filgrastim, hrG-CSF
11 Active, not recruiting Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma
Condition: Central Nervous System Lymphoma
Interventions: Drug: Methotrexate;   Drug: Ara-C;   Drug: Rituximab;   Drug: Thiotepa;   Radiation: radiotherapy;   Drug: BCNU;   Other: APBSCT
12 Recruiting Combination Chemotherapy With or Without Imatinib Mesylate and/or Peripheral Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: asparaginase;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: idarubicin;   Drug: imatinib mesylate;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: methylprednisolone;   Drug: mitoxantrone hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Procedure: allogeneic hematopoietic stem cell transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: radiation therapy
13 Active, not recruiting This is a Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM.
Conditions: Lymphoma (Non-Hodgkin's Lymphoma);   Hodgkin's Disease or Multiple Myeloma;   Front Line Mobilization;   Transplantation
Intervention: Drug: Generic = Plerixafor
14 Recruiting Bronchodilator Responsiveness in Bronchiolitis Obliterative Syndrome (BOS)
Condition: Bronchiolitis Obliterative Syndrome
Intervention: Drug: albuterol plus tiotropium
15 Recruiting Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis
Condition: Myelofibrosis
Intervention: Drug: Fludarabine, Melphalan +/- ATG
16 Recruiting Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia
Condition: Leukemia
Interventions: Biological: alemtuzumab;   Biological: filgrastim;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: fludarabine phosphate;   Drug: melphalan;   Drug: thiotepa;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation;   Procedure: peripheral blood stem cell transplantation
17 Completed Treatment of Adult ALL With an MRD-Directed Programme.
Condition: Acute Lymphoblastic Leukemia
Intervention: Behavioral: Postremission consolidation based on MRD status
18 Active, not recruiting Prophylactic Use of Maribavir for the Prevention of Cytomegalovirus (CMV) Disease in Stem Cell Transplant Recipients
Condition: Cytomegalovirus Infections
Interventions: Drug: maribavir;   Other: placebo
19 Recruiting High-Dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients
Condition: Hodgkin's Lymphoma
Intervention: Drug: ABVD
20 Recruiting Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma;   IPI≥2
Interventions: Drug: Rituximab;   Drug: Ciclofosfamide;   Drug: Doxorubicina;   Drug: Vincristina;   Drug: Prednisone;   Drug: Pegfilgrastim;   Drug: Mitoxantrone;   Drug: ARA-C;   Drug: Lenograstim;   Drug: BCNU;   Drug: VP-16;   Procedure: ASCT

 

 


Previous Page Studies Shown (1-20) Next Page (21-40)